Cargando…
Osteosarcoma growth suppression by riluzole delivery via iron oxide nanocage in nude mice
Osteosarcomas are the most commonly occurring malignant bone cancer in young individuals. The survival rate of patients with metastatic osteosarcoma is low and has been stagnant for over two decades. We previously demonstrated that the glutamate release inhibitor, riluzole inhibits osteosarcoma cell...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
D.A. Spandidos
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6921406/ https://www.ncbi.nlm.nih.gov/pubmed/31789402 http://dx.doi.org/10.3892/or.2019.7420 |